NCT04422366 2024-06-07Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy FemalesShanghai Bovax Biotechnology Co., Ltd.Phase 3 Recruiting8,000 enrolled